Biotechnological Innovations to Combat Antimicrobial Resistance and Advance Global Health Equity
Bacteria · 05.09.2025 · 4 (3) · 46
DOI: 10.3390/bacteria4030046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bacteria, online erschienen am 05.09.2025. Verfasst von Sima Rugarabamu und 1 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance (AMR) is a growing global health emergency that threatens the effectiveness of modern medicine, exacerbating healthcare costs, morbidity, and mortality, particularly in low- and middle-income countries (LMICs). Traditional approaches to antimicrobial development and stewardship have proven inadequate in curbing the rapid emergence and spread of resistant pathogens. This review explores cutting-edge biotechnological innovations as sustainable, precision-based solutions to combat AMR and promote global health equity. A comprehensive narrative review was conducted using literature published between 2018 and 2023 from PubMed, ScienceDirect, and Web of Science. Peer-reviewed studies focusing on novel antimicrobial strategies were thematically analyzed, with attention to efficacy, feasibility, and translational readiness. Key innovations identified include nanotechnology-enhanced antimicrobial delivery, bacteriophage therapy, CRISPR-Cas gene editing, immunotherapy, and personalized medicine. These strategies demonstrated substantial in vitro and in vivo efficacy, such as >90% MRSA biofilm reduction via silver nanoparticles and 95% carbapenem susceptibility restoration in E. coli using CRISPR-Cas9. When integrated with machine learning and rapid diagnostics, these approaches enable precision-targeted therapies and data-informed stewardship, offering scalable solutions adaptable to diverse healthcare systems. Antimicrobial resistance demands urgent, equitable innovation. Integrating biotechnologies like CRISPR, phage therapy, and nanomedicine with data-driven tools offers promising solutions. To ensure real-world impact, we recommend establishing regionally tailored translational research platforms and public–private partnerships as the most effective strategy to scale innovations and strengthen AMR response in low-resource settings.
Zitieren
APA
Rugarabamu, S., & Mwanyika, G. (2025). Biotechnological Innovations to Combat Antimicrobial Resistance and Advance Global Health Equity. Bacteria, 4(3), 46. https://doi.org/10.3390/bacteria4030046
Vancouver
Rugarabamu S, Mwanyika G. Biotechnological Innovations to Combat Antimicrobial Resistance and Advance Global Health Equity. Bacteria. 2025;4(3):46. doi:10.3390/bacteria4030046
BibTeX
@article{Rugarabamu2025,
author = {Rugarabamu, Sima and Mwanyika, Gaspary},
title = {Biotechnological Innovations to Combat Antimicrobial Resistance and Advance Global Health Equity},
journal = {Bacteria},
year = {2025},
volume = {4},
number = {3},
pages = {46},
doi = {10.3390/bacteria4030046}
}
EUVIMED